drugset / Trial / NCT03089138
Efficacy and Safety of Regan Tangjiang for Treating the Common Cold With Wind-heat Syndrome
RandomizedParallel-groupDouble-blindTreatment
Summary
Efficacy and Safety of Regan Tangjiang for treating the common cold with wind-heat syndrome: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled Phase 2b Study
Timeline
- Start
- 2017-03
- Primary completion
- 2018-03
- Completion
- 2018-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Regan Tangjiang | Unknown | — | — |
Indications
No indication recorded.